Americas Cancer Biologic Therapy Market

ID: MRFR/Pharma/0148-HCR

45 Pages

Rahul Gotadki

October 2025

Americas Cancer Biological Therapy market information, by type (Monoclonal Antibodies,  Gene Therapy, Colony-Stimulating Factors, Targeted Therapy and Others) by end users (hospitals & clinics, cancer research centers, laboratories) - Forecast to 2035

Americas Cancer Biologic Therapy Market Infographic

Summary Table of Contents Segmentation Download PDF

Americas Cancer Biologic Therapy Market Summary

The United States Americas Cancer Biological Therapy market is projected to grow from 98.4 USD Billion in 2024 to 133.4 USD Billion by 2035.

Key Market Trends & Highlights

Americas Cancer Biological Therapy Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 2.8 percent from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 133.4 USD Billion, indicating robust growth potential.
In 2024, the market is valued at 98.4 USD Billion, reflecting a strong foundation for future expansion.
Growing adoption of biological therapies due to increasing cancer prevalence is a major market driver.

Market Size & Forecast

2024 Market Size	98.4 (USD Billion)
2035 Market Size	133.4 (USD Billion)
CAGR (2025-2035)	2.8%

Major Players

Hoffmann-La Roche AG, GSK, Merck & Co., Novartis International AG, Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Amgen Inc., Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation

Key Companies in the Americas Cancer Biologic Therapy Market market include

Report Scope

Report Attribute/Metric	Details
Market Size 2023	90.2 (USD Billion)
Market Size 2024	98.4 (USD Billion)
Market Size 2032	104.7 (USD Billion)
Compound Annual Growth Rate (CAGR)	8.4 % (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023
Geographies Covered	US, Canada, and Rest of America
Key Vendors	Hoffmann-La Roche AG, GSK, Merck & Co., Novartis International AG, Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Amgen Inc., Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and others
Key Market Opportunities	Technological advances and funding available for the development of new therapeutics and treatment
Key Market Drivers	Increasing number of patients, limited option of therapy, patent expiry of cancer drug

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓